One Minute of Marijuana Secondhand Smoke Exposure Substantially Impairs Vascular Endothelial Function

Journal of the American Heart Association

Volumn 5, Issue 8, 2016, Pages

  Wang, Xiaoyin ^a   Derakhshandeh, Ronak ^a   Liu, Jiangtao ^a,b   Narayan, Shilpa ^a,c   Nabavizadeh, Pooneh ^a   Le, Stephenie ^a,d   Danforth, Olivia M ^a,e   Pinnamaneni, Kranthi ^a   Rodriguez, Hilda J ^a   Luu, Emmy ^a   Sievers, Richard E ^a   Schick, Suzaynn F ^a   Glantz, Stanton A ^a   Springer, Matthew L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CHINA JAPAN FRIENDSHIP HOSPITAL   (China)

^c DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^d ALBANY MEDICAL COLLEGE   (United States)

^e RUSH MEDICAL COLLEGE   (United States)

Author keywords

Artery; Cannabis; Endothelium; Flow mediated dilation; Marijuana; Nitric oxide synthase; Secondhand smoke; Smoking; Vasodilation

Indexed keywords

CANNABINOID; CANNABIS; GLYCERYL TRINITRATE; NICOTINE; TETRAHYDROCANNABINOL; NITRIC OXIDE; VASODILATOR AGENT;

ADVERSE EVENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANNABIS SMOKING; CARDIOVASCULAR EFFECT; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM; EXPOSURE; FEMALE; FEMORAL ARTERY FLOW; FLOW MEDIATED DILATION; FLOW-MEDIATED DILATION TEST; NONHUMAN; ONE MINUTE EXPOSURE; PASSIVE SMOKING; PRIORITY JOURNAL; RAT; RAT MODEL; TOBACCO; VASODILATATION; AIR POLLUTION; ANIMAL; CORONARY ARTERY BLOOD FLOW; DRUG EFFECTS; METABOLISM; PATHOPHYSIOLOGY; PERIPHERAL VASCULAR DISEASE; SMOKE; SPRAGUE DAWLEY RAT; TIME FACTOR; VASCULAR ENDOTHELIUM;

AIR POLLUTION; ANIMALS; CORONARY CIRCULATION; ENDOTHELIUM, VASCULAR; FEMALE; MARIJUANA SMOKING; NITRIC OXIDE; NITROGLYCERIN; PERIPHERAL VASCULAR DISEASES; RATS, SPRAGUE-DAWLEY; SMOKE; TIME FACTORS; VASODILATION; VASODILATOR AGENTS;

EID: 84989879766     PISSN: None     EISSN: 20479980     Source Type: Journal    
DOI: 10.1161/JAHA.116.003858     Document Type: Article

References (45)

1. Johnston LD, O'Malley P, Bachman JG. Monitoring the Future National Survey Results on Drug Use, 1975-2001. Volume I: Secondary school students (NIH Publication No. 02-5106). Bethesda, MD: National Institute on Drug Abuse; 2002.
2. Moir D, Rickert WS, Levasseur G, Larose Y, Maertens R, White P, Desjardins S. A comparison of mainstream and sidestream marijuana and tobacco cigarette smoke produced under two machine smoking conditions. Chem Res Toxicol. 2008;21:494-502.
3. O'Toole TE, Hellmann J, Wheat L, Haberzettl P, Lee J, Conklin DJ, Bhatnagar A, Pope CA III. Episodic exposure to fine particulate air pollution decreases circulating levels of endothelial progenitor cells. Circ Res. 2010;107:200-203.
4. Brook RD, Rajagopalan S, Pope CA III, Brook JR, Bhatnagar A, Diez-Roux AV, Holguin F, Hong Y, Luepker RV, Mittleman MA, Peters A, Siscovick D, Smith SC Jr, Whitsel L, Kaufman JD. Particulate matter air pollution and cardiovascular disease: an update to the scientific statement from the American Heart Association. Circulation. 2010;121:2331-2378.
5. Pope CA III, Burnett RT, Krewski D, Jerrett M, Shi Y, Calle EE, Thun MJ. Cardiovascular mortality and exposure to airborne fine particulate matter and cigarette smoke: shape of the exposure-response relationship. Circulation. 2009;120:941-948.
6. California Environmental Protection Agency. Proposed identification of environmental tobacco smoke as a toxic air contaminant. Part B: health effects. Sacramento, CA: California Environmental Protection Agency, Office of Environmental Health Hazard Assessment; 2005.
7. Barnoya J, Glantz SA. Cardiovascular effects of secondhand smoke: nearly as large as smoking. Circulation. 2005;111:2684-2698.
8. U.S. Department of Health and Human Services. The health consequences of involuntary exposure to tobacco smoke: a report of the Surgeon General. Atlanta, GA: U.S. Department of Health and Human Services; 2006.
9. Tan CE, Glantz SA. Association between smoke-free legislation and hospitalizations for cardiac, cerebrovascular, and respiratory diseases: a meta-analysis. Circulation. 2012;126:2177-2183.
10. Law B, Mason PA, Moffat AC, King LJ, Marks V. Passive inhalation of cannabis smoke. J Pharm Pharmacol. 1984;36:578-581.
11. Hayden JW. Passive inhalation of marijuana smoke: a critical review. J Subst Abuse. 1991;3:85-90.
12. Cone EJ, Bigelow GE, Herrmann ES, Mitchell JM, LoDico C, Flegel R, Vandrey R. Non-smoker exposure to secondhand cannabis smoke. I. Urine screening and confirmation results. J Anal Toxicol. 2015;39:1-12.
13. Barry RA, Hiilamo H, Glantz SA. Waiting for the opportune moment: the tobacco industry and marijuana legalization. Milbank Q. 2014;92:207-242.
14. Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID, Lloyd JK, Deanfield JE. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet. 1992;340:1111-1115.
15. Pyke KE, Tschakovsky ME. The relationship between shear stress and flow-mediated dilatation: implications for the assessment of endothelial function. J Physiol. 2005;568:357-369.
16. Flammer AJ, Anderson T, Celermajer DS, Creager MA, Deanfield J, Ganz P, Hamburg NM, Luscher TF, Shechter M, Taddei S, Vita JA, Lerman A. The assessment of endothelial function: from research into clinical practice. Circulation. 2012;126:753-767.
17. Anderson TJ, Uehata A, Gerhard MD, Meredith IT, Knab S, Delagrange D, Lieberman EH, Ganz P, Creager MA, Yeung AC, Selwyn AP. Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol. 1995;26:1235-1241.
18. Ganz P, Vita JA. Testing endothelial vasomotor function: nitric oxide, a multipotent molecule. Circulation. 2003;108:2049-2053.
19. Widlansky ME, Gokce N, Keaney JF Jr, Vita JA. The clinical implications of endothelial dysfunction. J Am Coll Cardiol. 2003;42:1149-1160.
20. Nabel EG, Selwyn AP, Ganz P. Large coronary arteries in humans are responsive to changing blood flow: an endothelium-dependent mechanism that fails in patients with atherosclerosis. J Am Coll Cardiol. 1990;16:349-356.
21. Yeboah J, Crouse JR, Hsu FC, Burke GL, Herrington DM. Brachial flow-mediated dilation predicts incident cardiovascular events in older adults: the Cardiovascular Health Study. Circulation. 2007;115:2390-2397.
22. Yeboah J, Sutton-Tyrrell K, McBurnie MA, Burke GL, Herrington DM, Crouse JR. Association between brachial artery reactivity and cardiovascular disease status in an elderly cohort: the Cardiovascular Health Study. Atherosclerosis. 2008;197:768-776.
23. Yeboah J, Folsom AR, Burke GL, Johnson C, Polak JF, Post W, Lima JA, Crouse JR, Herrington DM. Predictive value of brachial flow-mediated dilation for incident cardiovascular events in a population-based study: the Multi-Ethnic Study of Atherosclerosis. Circulation. 2009;120:502-509.
24. Celermajer DS, Sorensen KE, Georgakopoulos D, Bull C, Thomas O, Robinson J, Deanfield JE. Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults. Circulation. 1993;88:2149-2155.
25. Celermajer DS, Adams MR, Clarkson P, Robinson J, McCredie R, Donald A, Deanfield JE. Passive smoking and impaired endothelium-dependent arterial dilatation in healthy young adults. N Engl J Med. 1996;334:150-154.
26. Frey PF, Ganz P, Hsue PY, Benowitz NL, Glantz SA, Balmes JR, Schick SF. The exposure-dependent effects of aged secondhand smoke on endothelial function. J Am Coll Cardiol. 2012;59:1908-1913.
27. Heiss C, Amabile N, Lee AC, Real WM, Schick SF, Lao D, Wong ML, Jahn S, Angeli FS, Minasi P, Springer ML, Hammond SK, Glantz SA, Grossman W, Balmes JR, Yeghiazarians Y. Brief secondhand smoke exposure depresses endothelial progenitor cells activity and endothelial function: sustained vascular injury and blunted nitric oxide production. J Am Coll Cardiol. 2008;51:1760-1771.
28. Kato T, Inoue T, Morooka T, Yoshimoto N, Node K. Short-term passive smoking causes endothelial dysfunction via oxidative stress in nonsmokers. Can J Physiol Pharmacol. 2006;84:523-529.
29. Li Z, Barrios V, Buchholz JN, Glenn TC, Duckles SP. Chronic nicotine administration does not affect peripheral vascular reactivity in the rat. J Pharmacol Exp Ther. 1994;271:1135-1142.
30. Weber LP, Al-Dissi A, Marit JS, German TN, Terletski SD. Role of carbon monoxide in impaired endothelial function mediated by acute second-hand tobacco, incense, and candle smoke exposures. Environ Toxicol Pharmacol. 2011;31:453-459.
31. Mills NL, Tornqvist H, Robinson SD, Gonzalez M, Darnley K, MacNee W, Boon NA, Donaldson K, Blomberg A, Sandstrom T, Newby DE. Diesel exhaust inhalation causes vascular dysfunction and impaired endogenous fibrinolysis. Circulation. 2005;112:3930-3936.
32. Heiss C, Sievers RE, Amabile N, Momma TY, Chen Q, Natarajan S, Yeghiazarians Y, Springer ML. In vivo measurement of flow-mediated vasodilation in living rats using high resolution ultrasound. Am J Physiol Heart Circ Physiol. 2008;294:H1086-H1093.
33. Chen Q, Sievers RE, Varga M, Kharait S, Haddad DJ, Patton AK, Delany CS, Mutka SC, Blonder JP, Dube GP, Rosenthal GJ, Springer ML. Pharmacological inhibition of S-nitrosoglutathione reductase improves endothelial vasodilatory function in rats in vivo. J Appl Physiol. 2013;114:752-760.
34. Pinnamaneni K, Sievers RE, Sharma R, Selchau AM, Gutierrez G, Nordsieck EJ, Su R, An S, Chen Q, Wang X, Derakhshandeh R, Aschbacher K, Heiss C, Glantz SA, Schick SF, Springer ML. Brief exposure to secondhand smoke reversibly impairs endothelial vasodilatory function. Nicotine Tob Res. 2014;16:584-590.
35. Liu J, Wang X, Narayan S, Glantz SA, Schick SF, Springer ML. Impairment of endothelial function by little cigar secondhand smoke. Tob Regul Sci. 2016;2:56-63.
36. California Environmental Protection Agency. Proposed identification of environmental tobacco smoke as a toxic air contaminant. Part A: exposure assessment. Sacramento, CA: California Environmental Protection Agency, Office of Environmental Health Hazard Assessment ed: California Environmental Protection Agency; 2005.
37. Ashton CH. Pharmacology and effects of cannabis: a brief review. Br J Psychiatry. 2001;178:101-106.
38. Mittleman MA, Lewis RA, Maclure M, Sherwood JB, Muller JE. Triggering myocardial infarction by marijuana. Circulation. 2001;103:2805-2809.
39. Jouanjus E, Lapeyre-Mestre M, Micallef J. Cannabis use: signal of increasing risk of serious cardiovascular disorders. J Am Heart Assoc. 2014;3:e000638 doi: 10.1161/JAHA.113.000638.
40. Thomas G, Kloner RA, Rezkalla S. Adverse cardiovascular, cerebrovascular, and peripheral vascular effects of marijuana inhalation: what cardiologists need to know. Am J Cardiol. 2014;113:187-190.
41. Barua RS, Ambrose JA, Eales-Reynolds LJ, DeVoe MC, Zervas JG, Saha DC. Dysfunctional endothelial nitric oxide biosynthesis in healthy smokers with impaired endothelium-dependent vasodilatation. Circulation. 2001;104:1905-1910.
42. Barua RS, Ambrose JA, Srivastava S, DeVoe MC, Eales-Reynolds LJ. Reactive oxygen species are involved in smoking-induced dysfunction of nitric oxide biosynthesis and upregulation of endothelial nitric oxide synthase: an in vitro demonstration in human coronary artery endothelial cells. Circulation. 2003;107:2342-2347.
43. Ferguson R. Using medical marijuana now OK in public places in Ontario under new regulations. Toronto Star. 2015. November 25, 2015.
44. Ferguson R. Ontario government taking medical marijuana plan back to the drawing board. Toronto Star. 2015. November 26, 2015.
45. Herrmann ES, Cone EJ, Mitchell JM, Bigelow GE, LoDico C, Flegel R, Vandrey R. Non-smoker exposure to secondhand cannabis smoke II: effect of room ventilation on the physiological, subjective, and behavioral/cognitive effects. Drug Alcohol Depend. 2015;151:194-202.